GE HealthCare Technologies Inc. (GEHC) company profile
Close on Nov 18, 2026Market cap $37.83BP/E 17.6Yield 0.17%
About GE HealthCare Technologies
X-Ray Apparatus & Tubes & Related Irradiation Apparatus, SIC 3844
GE HealthCare Technologies Inc. operates as a medical technology, pharmaceutical diagnostics, and digital healthcare solutions provider. The company develops and distributes diagnostic imaging systems, patient monitoring devices, ultrasound systems, surgical visualization tools, life support equipment, consumable clinical accessories, and contrast agents. It organizes its business operations into four core segments: Imaging, Advanced Visualization Solutions, Patient Care Solutions, and Pharmaceutical Diagnostics. Alongside physical equipment and pharmaceuticals, the enterprise delivers artificial intelligence tools, cloud platforms, workflow software, and maintenance services. Its client base includes public and private hospitals, integrated health systems, research organizations, academic centers, and government institutions.
The enterprise maintains a global commercial footprint across more than 160 countries. Its international infrastructure includes manufacturing, assembly, and pharmaceutical production operations situated across 44 facilities in 17 countries. The company employs roughly 54,000 colleagues globally, including specialized workforces of approximately 9,700 sales representatives, 8,900 field service engineers, and 11,100 research scientists and engineers. GE HealthCare Technologies Inc. maintains its corporate headquarters in Chicago, Illinois.
Summary of the business section of GE HealthCare Technologies's latest annual report, written by StockData.
Company profile
Company
- Legal name
- GE HealthCare Technologies Inc.
- Founded
- 2004
- Headquarters
- Chicago, IL
- Address
- 500 West Monroe Street 60661
- Phone
- (833) 735-1139
- Website
- www.gehealthcare.com
- Employees
- 54,000, Dec 31, 2025
- Industry
- X-Ray Apparatus & Tubes & Related Irradiation Apparatus
- Incorporated in
- Delaware
- Fiscal year ends
- December 31
- Auditor
- Deloitte & Touche LLP, Chicago, Illinois
Stock & identifiers
- Ticker
- GEHC
- Exchange
- Nasdaq
- IPO date
- Dec 15, 2022
- Shares outstanding
- 452M, Oct 21, 2026
- Public float
- $34.00B, Jun 30, 2025
- Filer category
- Large accelerated filer
- SEC CIK
- 1932393
- CUSIP
- 36266G107
- ISIN
- US36266G1076
- FIGI
- BBG01BFR8YV1
- Share class FIGI
- BBG01BFR8YW0
- LEI
- 549300OI9J7XOWZMUN85
- EIN
- 88-2515116
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Peter J. Arduini | President and CEO, Director | 241,606 |
| William K. Grogan | Chief Financial Officer | 75,096 |
| Adam Y. Holton | Chief People Officer | 19,533 |
| Taha Kass-Hout | Chief Technology Officer | 88,467 |
| Philip Rackliffe | CEO, AIS | 41,533 |
| George A. Newcomb | Chief Accounting Officer | 10,527 |
| Frank R. Jimenez | GC & Corporate Secretary | 89,321 |
| Catherine Estrampes | Chief Commer. & Growth Officer | 23,573 |
| Kevin Michael O'Neill | CEO, PDx | 32,085 |
| Jeannette Bankes | CEO, Patient Care Solutions | 37,293 |
| James Saccaro | Chief Financial Officer | 87,471 |
| Roland Rott | CEO, Imaging | 41,082 |
| Kenneth R. Stacherski | Chief Enterprise Oper. Officer | 40,996 |
| Thomas J. Westrick | CEO, Patient Care Solutions | 18,501 |
| Kevin Lobo | Director | 14,363 |
| Rodney F. Hochman | Director | 21,504 |
| H. Lawrence Culp Jr | Director | 499,917 |
| Watkin Phoebe L. Yang | Director | 13,702 |
| Catherine A. Lesjak | Director | 12,702 |
| William J. Stromberg | Director | 18,916 |
| Anne T. Madden | Director | 19,479 |
| Tomislav Mihaljevic | Director | 9,116 |
| Lloyd Howell Jr | Director | 9,116 |
| Risa J. Lavizzo-Mourey | Director | 10,157 |
CEO pay and shareholder return
Pay versus performance table from the proxy statement
| Fiscal year | CEO total pay | CEO pay actually paid | Other executives (avg) | Value of $100 invested | Peer group |
|---|---|---|---|---|---|
| FY2025 | $18.56M | $19.55M | $5.69M | $136 | $122 |
| FY2024 | $19.49M | $13.41M | $5.18M | $130 | $114 |
| FY2023 | $24.51M | $29.85M | $9.13M | $128 | $101 |
| FY2022 | $10.50M | $7.34M | $4.71M | – | – |
“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.
Executive compensation, fiscal 2025
Summary compensation table from the latest proxy statement
| Executive | Salary | Bonus | Stock awards | Option awards | Incentive pay | Other | Total | vs. prior year |
|---|---|---|---|---|---|---|---|---|
| Peter J. Arduini President and CEO | $1.32M | $0 | $11.25M | $3.62M | $2.08M | $282.22K | $18.56M | -5% |
| James Saccaro VP and CFO | $890.42K | $0 | $3.03M | $974.98K | $909.00K | $93.23K | $5.89M | +4% |
| Taha Kass-Hout Chief Science and Technology Officer | $897.12K | $3.25K | $3.10M | $999.98K | $909.00K | $93.22K | $6.01M | +5% |
| Frank Jimenez General Counsel and Corporate Secretary | $890.42K | $0 | $2.72M | $874.98K | $909.00K | $108.31K | $5.50M | +2% |
| Jeannette Bankes President and CEO, Patient Care Solutions | $439.94K | $160.00K | $3.72M | $499.98K | $363.92K | $171.80K | $5.36M | – |
Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.
Employees
Headcount reported in annual reports
“We are a purpose-driven global workforce of approximately 54,000 colleagues with an average tenure that reflects a strong, engaged culture.”
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| Apr 25, 2023 | Merger | Registration of securities for a merger or exchange offer (S-4) |
| Dec 14, 2022 | Name change | Name changed from GE Healthcare Holding LLC to GE HealthCare Technologies Inc. |
| Oct 11, 2022 | Spin-off | Registration as a new public company (Form 10), e.g. spin-off |
See a number that looks wrong?